Health & Biotechnology
Supporting the next generation of global bioinnovation
Brampton’s Health & Biotechnology companies are part of an internationally renowned cluster of organizations within the Greater Toronto Area (GTA) that include pharmaceutical manufacturing, medical equipment and supplies, and medical and diagnostic laboratories.
These innovative companies enjoy access to some of the most advanced university-based researchers, world-class talent and Canada’s largest clinical trial infrastructure
The new $500 million world-class Peel Memorial Centre for Integrated Health and Wellness (PMC) has spurred the development of a new Health and Biotechnology cluster in the downtown centre of Brampton. This health cluster is uniquely focused on preventive care and targets businesses involved with big data, health applications, population-based research and personalized medicine
There are thousands of health-sector businesses and agencies in Brampton, from doctors’ offices to global players in medical research and devices, including Medtronic (HQ), Taro Pharmaceuticals (HQ), Dynacare and Canadian Blood Services.
Brampton boasts three leading health care facilities: William Osler Health System (Peel Memorial and Brampton Civic) and ErinoakKids.
Enrollment in life science-related programs within commuting distance of Brampton has tripled since 2006. There are now more than 24,000 students in health and health-related fields in the city.
Brampton is also home to Sheridan College’s Faculty of Applied Health & Community Studies and there are over 300 life science-related programs offered at the 21 universities and colleges and 25 private career colleges located within an hour’s drive of the city.
To support innovation in this thriving health and biotechnology cluster, BHive has developed a sector-specific incubation program to help foreign start-ups provide solutions to the world’s most pressing healthcare challenges.
Working to provide solutions to the world’s most pressing healthcare challenges.
Who should apply
Our Healthcare cohort is suited to future-thinking, coachable founders building proprietary technologies, advanced research, complex models, and unique designs to innovate healthcare for hospitals, nursing homes, long-term care centres, hospices, patients, and their families.
This cohort is aimed toward early-stage companies (pre-seed, seed, or Series), whether they have raised little to no investment or even projects (pre-incorporation); however, start-ups at all levels of the company life cycle will be considered.
Companies with any or all the following are preferred:
- Published Research
- FDA Approved
- Government Approved
- Clinical Trials completed
- Digital Health
- Medical Devices
- Diagnostic tools and equipment
- Healthcare Software
- Wellness and Mental Health
- Cognition – Brain Health
- Senior Health Care
- Drug Development
Benefits at BHive
Access to funding
Labs & research facilities
Dedicated Sector Manager
At BHive innovative companies enjoy access to some of the most advanced university-based researchers, world-class talent & Canada’s largest clinical trial infrastructure.
Ready to take the next step?
Are you a fast-growing foreign start-up looking to expand into North America? Get in touch with the BHive team to see how we can help accelerate your North American expansion.